These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19745062)

  • 21. Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS/MS.
    Valen A; Leere Øiestad ÅM; Strand DH; Skari R; Berg T
    Drug Test Anal; 2017 May; 9(5):808-823. PubMed ID: 27464485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of rapid point-of-collection oral fluid drug-testing devices.
    Walsh JM; Flegel R; Crouch DJ; Cangianelli L; Baudys J
    J Anal Toxicol; 2003 Oct; 27(7):429-39. PubMed ID: 14606995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of the first comprehensive state oral fluid drug testing program for roadside screening and laboratory testing in DUID cases-A 5-year review.
    Harper CE; Hudson JS; Tidwell K; Boswell R; Yong HL; Maxwell AJ
    J Anal Toxicol; 2023 Nov; 47(8):694-702. PubMed ID: 37526020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of the Cozart DDS oral fluid collection device.
    Speedy T; Baldwin D; Jowett G; Gallina M; Jehanli A
    Forensic Sci Int; 2007 Aug; 170(2-3):117-20. PubMed ID: 17624706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Drugs in Oral Fluid Using LC-MS/MS.
    Coulter CA; Moore CM
    Methods Mol Biol; 2019; 1872():237-259. PubMed ID: 30350295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration.
    Scheidweiler KB; Spargo EA; Kelly TL; Cone EJ; Barnes AJ; Huestis MA
    Ther Drug Monit; 2010 Oct; 32(5):628-37. PubMed ID: 20814350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Illicit Drugs in Oral Fluid: Evaluation of Two Collection Devices.
    Cohier C; Mégarbane B; Roussel O
    J Anal Toxicol; 2017 Jan; 41(1):71-76. PubMed ID: 27681339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First nationwide study on driving under the influence of drugs in Switzerland.
    Senna MC; Augsburger M; Aebi B; Briellmann TA; Donzé N; Dubugnon JL; Iten PX; Staub C; Sturm W; Sutter K
    Forensic Sci Int; 2010 May; 198(1-3):11-6. PubMed ID: 20211534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
    Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
    Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hair analysis of abused and therapeutic drugs in forensic toxicology].
    Klausz G; Kass K; Sótonyi P; Róna K
    Orv Hetil; 2006 Nov; 147(45):2181-6. PubMed ID: 17402212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current knowledge on cannabinoids in oral fluid.
    Lee D; Huestis MA
    Drug Test Anal; 2014; 6(1-2):88-111. PubMed ID: 23983217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of selected oral fluid point-of-collection drug-testing devices.
    Crouch DJ; Walsh JM; Flegel R; Cangianelli L; Baudys J; Atkins R
    J Anal Toxicol; 2005; 29(4):244-8. PubMed ID: 15975256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.
    Röhrich J; Zörntlein S; Becker J; Urban R
    J Anal Toxicol; 2010 Apr; 34(3):155-61. PubMed ID: 20406540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
    Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
    Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suspicion of driving under the influence of alcohol or drugs: Cross sectional analysis of drug prevalence in the context of the Swiss legislation.
    Maurer J; Vergalito E; Prior AF; Donzé N; Thomas A; Augsburger M
    Forensic Sci Int; 2021 Dec; 329():111081. PubMed ID: 34741989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioids in oral fluid of Spanish drivers.
    Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Álvarez FJ
    Drug Alcohol Depend; 2018 Jun; 187():35-39. PubMed ID: 29626744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges.
    Verstraete AG
    Forensic Sci Int; 2005 Jun; 150(2-3):143-50. PubMed ID: 15944054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
    Marin SJ; Keith L; Merrell M; McMillin GA
    J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.